VMC Members[close]

Login

Not yet a member?

Stay up to date with
the latest health news




Are you a Health Professional?

Read more detailed and referenced information written by Australian health professionals, make sure you select health professional in the signup form!

The factor that could determine future breast cancer treatment

Australian scientists have shown how a ‘transcription factor’ causes breast cancer to develop an aggressive subtype that lacks sensitivity to oestrogen and does not respond to anti-oestrogen therapies such as Tamoxifen and aromatase inhibitors.

Transcription factors are molecules that switch genes on or off. In this case, the transcription factor known as ‘ELF5’ inhibits sensitivity to oestrogen very early in the life of a breast cancer cell.

In 2008, Associate Professor Chris Ormandy from Sydney’s Garvan Institute of Medical Research showed that ELF5 was responsible for the development of the oestrogen-receptor-negative cells in the breast during pregnancy that produce milk.

In the current study Ormandy, in collaboration with Drs Maria Kalyuga and David Gallego-Ortega, has shown that the same molecular decision occurs in breast cancer and that ELF5 has the ability to change an existing tumour to an oestrogen-insensitive type.

The team has also described the genetic mechanisms by which ELF5 opposes the action of oestrogen, and has shown that it is possible to alter the subtype of breast cancer by manipulating ELF5 levels. The findings are published in the highly prestigious journal PLoS Biology, now online.

“This work tells us that cancers which become refractory to anti-oestrogen treatment often do so by elevating their levels of ELF5 and becoming functionally oestrogen receptor negative,” said Ormandy.

“This raises the therapeutic option of manipulating ELF5 levels to treat breast cancer.”

“As ELF5 is intracellular, this could possibly be done with small molecule therapies that target protein-to-protein interactions, or with small inhibitory RNAs.”

“There is also the possibility of testing ELF5 levels in tumours to predict response to treatment and therefore guide treatment decisions.”

“Our key discovery here is that by simply manipulating one transcription factor we can change the subtype of breast cancer.


(Source: Garvan Institute: PLoS Biology)

More information

Breast cancer
For more information on breast cancer, types of breast cancer and its investigations and treatments, as well as some useful videos, see
Breast Cancer.


calendar icon Article Date: 13/1/2013

 

Related Articles:


Connect

Sign up for free newsletter Sign up for free newsletters
News RSS feeds Subscribe to RSS feeds
Discuss on Forum Discuss on Forum
share this page with others

 

Article Comments

Add your comment to this article





 Change Code


 Enter the above security Code

User-generated Content Guidelines

Rate this article

Current Sponsors
About Virtualmedicalcentre.com

Virtual Medical Centre

Australia’s leading source for trustworthy medical information written by health professionals.

Please be aware that we do not give advice on your individual medical condition,
if you want advice please see your treating physician.

Virtual Medical Centre © 2002 - 2013 | Privacy Policy Last updated 21 May 2013

Parenting information is available at Parenthub.com.au

^ Back to Top
 
Partners and Accreditations
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.
Health insite MindHealth Connect Pregnancy Birth and Baby
PANDORA is a digital archive dedicated to the preservation of and long term access to Australian online electronic publications of national significance Parenthub.com.au for parenting information
For banner advertising
Multi Channel Network
Website and videos by
Titan Web
Titan Web Clients
Web Design Perth
close

Join our FREE fortnightly health newsletter!

Simply enter your email address below:


No, Thanks!

Virtual Medical Centre respects your privacy.
You can unsubscribe from the newsletter at any time.
Please read our Terms of Use and Privacy Policy.

Health Professionals signup for the professional newsletter!

Are your a health professional?
Sign up to receive our dedicated newsletter for health professionals